← Open Payments lookup

CHELSEA REESE: Open Payments

NPI 1831680933 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$586 in 30 payments from 12 companies in 2025. Trend: 2023 $722 · 2024 $1,612 · 2025 $586

Food & beverage: $586
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.5$135
ABBVIE INC.5$99
Arcutis Biotherapeutics, Inc.3$56
Galderma Laboratories, L.P.3$51
MAYNE PHARMA COMMERCIAL LLC4$49
GENZYME CORPORATION1$48
Organon LLC3$38
UCB, Inc.2$33
Paratek Pharmaceuticals, Inc.1$27
Boehringer Ingelheim Pharmaceuticals, Inc.1$21

Products named: DUPIXENT, SKYRIZI, Zoryve, NEMLUVIO, RINVOQ, Bimzelx, LIBTAYO, NUZYRA.

Industry payments across TX — which companies pay providers there.